During the recent session, Geron Corporation (NASDAQ:GERN)’s traded shares were 6.99 million, with the beta value of the company hitting 0.88. At the last check today, the stock’s price was $3.47, reflecting an intraday gain of 11.02% or $0.34. The 52-week high for the GERN share is $3.84, that puts it down -10.66 from that peak though still a striking 65.99% gain since the share price plummeted to a 52-week low of $1.18. The company’s market capitalization is $1.54B, and the average intraday trading volume over the past 10 days was 5.84 million shares, and the average trade volume was 5.68 million shares over the past three months.

Geron Corporation (GERN) received a consensus recommendation of an Overweight from analysts. That translates to a mean rating of 1.70. GERN has a Sell rating from 0 analyst(s) out of 6 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 1 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.08.

Geron Corporation (NASDAQ:GERN) trade information

Geron Corporation (GERN) registered a 11.02% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 11.02% in intraday trading to $3.47 this Thursday, 05/25/23, hitting a weekly high. The stock’s 5-day price performance is 12.82%, and it has moved by 46.01% in 30 days. Based on these gigs, the overall price performance for the year is 169.38%. The short interest in Geron Corporation (NASDAQ:GERN) is 23.61 million shares and it means that shorts have 4.01 day(s) to cover.

The consensus price target of analysts on Wall Street is $4.83, which implies an increase of 28.16% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $4.00 and $6.00 respectively. As a result, GERN is trading at a discount of -72.91% off the target high and -15.27% off the low.

Geron Corporation (GERN) estimates and forecasts

Statistics show that Geron Corporation has underperformed its competitors in share price, compared to the industry in which it operates. Geron Corporation (GERN) shares have gone up 57.95% during the last six months, with a year-to-date growth rate less than the industry average at 2.70% against 11.70. In the rating firms’ projections, revenue will decrease -69.80% compared to the previous financial year.

Revenue for the current quarter is expected to be $70k as predicted by 6 analyst(s). Meanwhile, a consensus of 6 analyst(s) estimates revenue growth to $70k by the end of Sep 2023. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled $73k and $90k respectively. In this case, analysts expect current quarter sales to shrink by -4.10% and then drop by -22.20% in the coming quarter.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -16.30%. While earnings are projected to return -5.10% in 2023, the next five years will return 5.00% per annum.

GERN Dividends

Geron Corporation is due to release its next quarterly earnings between August 09 and August 14. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.

Geron Corporation (NASDAQ:GERN)’s Major holders

Geron Corporation insiders own 0.13% of total outstanding shares while institutional holders control 44.85%, with the float percentage being 44.91%. RA Capital Management, L.P. is the largest shareholder of the company, while 242 institutions own stock in it. As of Mar 30, 2023, the company held over 31.54 million shares (or 6.20% of all shares), a total value of $68.45 million in shares.

The next largest institutional holding, with 31.5 million shares, is of Blackrock Inc.’s that is approximately 6.19% of outstanding shares. At the market price on Mar 30, 2023, these shares were valued at $68.35 million.

Also, the Mutual Funds coming in first place with the largest holdings of Geron Corporation (GERN) shares are Vanguard Total Stock Market Index Fund and SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF. Data provided on Dec 30, 2022 indicates that Vanguard Total Stock Market Index Fund owns about 11.61 million shares. This amounts to just over 2.28 percent of the company’s overall shares, with a $28.1 million market value. The same data shows that the other fund manager holds slightly less at 10.86 million, or about 2.14% of the stock, which is worth about $30.2 million.